Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Pyridinemethanamine,3-methyl-N-[(3-methyl-2-pyridinyl)methyl]-(9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

780801-97-0

Post Buying Request

780801-97-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

780801-97-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 780801-97-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,8,0,8,0 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 780801-97:
(8*7)+(7*8)+(6*0)+(5*8)+(4*0)+(3*1)+(2*9)+(1*7)=180
180 % 10 = 0
So 780801-97-0 is a valid CAS Registry Number.

780801-97-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name bis-(3-methyl-pyridin-2-ylmethyl)-amine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:780801-97-0 SDS

780801-97-0Upstream product

780801-97-0Downstream Products

780801-97-0Relevant articles and documents

ACYCLIC CXCR4 INHIBITORS AND USES THEREOF

-

Paragraph 00193; 00202; 00216, (2019/07/13)

The present invention relates to compounds and methods useful for modulation, e.g. inhibition, of C-X-C receptor type 4 (CXCR4). The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using the compositions in the treatment of various disorders.

CXCR4 chemokine receptor binding comounds

-

Page 80, (2010/02/08)

The present invention relates to compounds that bind to chemokine receptors, and having the formula wherein each A, X, Y, R1, R2 and R3 are substituents. The present invention also relates to methods of using such compounds, such as in treating HIV infection and inflammatory conditions such as rheumatoid arthritis. Furthermore, the present invention relates to methods to elevate progenitor and stem cell counts, as well as methods to elevate white blood cell counts, using such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 780801-97-0